IG
BIIB icon

Ithaka Group’s Biogen BIIB Stock Holding History

Ithaka Group’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-18,091
Closed -$5.13M – 43
2016
Q4 		$5.13M Sell
18,091
-3,335
-16% -$989K 1.01% 33
2016
Q3 		$6.71M Sell
21,426
-3,620
-14% -$1.07M 1.05% 34
2016
Q2 		$6.06M Buy
25,046
+30
+0.1% +$7.91K 0.88% 35
2016
Q1 		$6.51M Sell
25,016
-21,325
-46% -$5.63M 0.94% 32
2015
Q4 		$14.2M Buy
46,341
+2,301
+5% +$661K 1.89% 21
2015
Q3 		$12.9M Buy
44,040
+5,512
+14% +$1.82M 1.97% 23
2015
Q2 		$15.6M Sell
38,528
-3,088
-7% -$1.24M 2.62% 16
2015
Q1 		$17.6M Buy
41,616
+11,689
+39% +$4.61M 2.78% 15
2014
Q4 		$10.2M Sell
29,927
-2,009
-6% -$650K 1.59% 29
2014
Q3 		$10.6M Sell
31,936
-917
-3% -$302K 1.58% 30
2014
Q2 		$10.4M Buy
+32,853
New +$9.89M 1.5% 30

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Ithaka Group's BIIB Position: Q1 2017 in Review

Ithaka Group sold out of Biogen (BIIB) in Q1 2017, closing a stake of 18,091 shares — an estimated $5.13M sold.

Ithaka Group first reported a position in BIIB in Q2 2014 and held it in 11 quarters. The position peaked at $17.6M in Q1 2015. 1,019 funds tracked by Wall St. Rank hold BIIB as of Q1 2017.

  • Ithaka Group reported no remaining Biogen position as of Q1 2017 after selling out during the quarter.
  • Ithaka Group sold 18,091 Biogen shares in Q1 2017, an estimated $5.13M.
  • Ithaka Group first reported a position in Biogen in Q2 2014 and held it in 11 quarters.
  • Ithaka Group's Biogen position peaked at $17.6M in Q1 2015.
  • 1,019 funds tracked by Wall St. Rank held Biogen as of Q1 2017.

Based on Ithaka Group's 13F filing for Q1 2017, filed 9 May 2017.